MolVerse is an innovative global first deeptech company bringing accessibility and sustainability to preclinical drug development and beyond using a “novel disruptive approach reducing the need for animal models” in life sciences, human diseases and drug development. 

Unveiling Innovative Breakthroughs: Pioneering novelty and reproducibility for sustainable biomolecular and preclinical discovery and development:

Understanding structure-function relationships of proteins, viruses, and biological macromolecules is at the heart of life sciences research, disease biology, drug development, and beyond. Embracing the mission to "Accelerate Molecular Discoveries," we bring cutting-edge solutions to unraveling the mysteries of bio-macromolecules for preclinical studies. Dive into efficiency, affordability, and reproducibility by reducing costs and time investment. 

MolVerse's unique product and services pipeline minimizes data collection by over 40%, making complex structural biology more approachable and efficient. Powered by quantum chemistry, high-throughput cryogenic electron microscopy, and GPU-accelerated high-performance computing, we weave together machine learning and image processing for captivating near-atomic 3D maps, presenting the marvels of molecular exploration to a diverse audience. Step into the realm where deep tech and science meet with us! 

Humane and Sustainable Approach

Our approach reduces reliance on animal model studies for human healthcare/medicine and enables the direct study of human and pathogenic samples with minimal processing. It expands the application beyond pure samples to broader molecular biology, biochemical, virological studies, etc. This innovation empowers academic or hospital-centric research institutes and pharmaceutical companies to save millions in costs and resources, obtaining accurate, evidence-based 3D maps as a platform for reproducible drug discovery and development pipelines even without antibodies.

MolVerse

Org chart

Teams

Offices